Literature DB >> 8399832

EEG manifestations during ECT: effects of electrode placement and stimulus intensity.

M S Nobler1, H A Sackeim, M Solomou, B Luber, D P Devanand, J Prudic.   

Abstract

This study examined the ictal electroencephalographic (EEG) characteristics of four forms of electroconvulsive therapy (ECT) known to differ in efficacy. Previously, we demonstrated that titrated, low-dose right unilateral ECT reliably produces generalized seizures of adequate duration, but is remarkably weak in antidepressant effects. Using a new rating scale, we found that specific features of the ictal and immediate postictal EEG varied significantly with ECT stimulus intensity and electrode placement. The low-dose right unilateral condition differed from more effective forms of ECT in having the longest polyspike phase duration, averaging twice that of the other conditions; it was also the condition least likely to manifest bioelectric suppression immediately following seizure termination. In contrast, high-dose bilateral ECT--a treatment with particularly rapid antidepressant effects--resulted in the greatest peak slow-wave amplitude in both hemispheres. Total seizure duration did not differ among the four treatment conditions. These findings indicate that seizure duration is not a useful marker of therapeutic efficacy, and instead provide preliminary evidence that other features of the EEG may be more useful markers of treatment adequacy.

Entities:  

Mesh:

Year:  1993        PMID: 8399832     DOI: 10.1016/0006-3223(93)90089-v

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  23 in total

Review 1.  [Value of diagnostic imaging in evaluation of electroconvulsive therapy].

Authors:  T Frodl; E M Meisenzahl; H-J Möller
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

2.  Central-Positive Complexes: A Novel Characterization of Ictal Markers Induced During Electroconvulsive Therapy.

Authors:  R Edward Hogan; Emma R Trammel; Nuri B Farber; Michael S Avidan; Ben Julian A Palanca
Journal:  J ECT       Date:  2019-12       Impact factor: 3.635

3.  Seizure threshold increases can be predicted by EEG quality in right unilateral ultrabrief ECT.

Authors:  Verònica Gálvez; Dusan Hadzi-Pavlovic; Susan Waite; Colleen K Loo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-11       Impact factor: 5.270

4.  An Electrophysiological Biomarker That May Predict Treatment Response to ECT.

Authors:  Katherine W Scangos; Richard D Weiner; Edward C Coffey; Andrew D Krystal
Journal:  J ECT       Date:  2019-06       Impact factor: 3.635

5.  The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy.

Authors:  H Folkerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 6.  [Electroconvulsive therapy for the treatment of major depression].

Authors:  D Zilles; C Wolff-Menzler; J Wiltfang
Journal:  Nervenarzt       Date:  2015-05       Impact factor: 1.214

7.  Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.

Authors:  Jan Malte Bumb; Suna Su Aksay; Christoph Janke; Laura Kranaster; Olga Geisel; Peter Gass; Rainer Hellweg; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-18       Impact factor: 5.270

8.  Brief vs. ultrabrief pulse ECT: focus on seizure quality.

Authors:  Isabelle Brunner; Michael Grözinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-18       Impact factor: 5.270

9.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

10.  [Electroconvulsive therapy at the Department of Psychiatry and Psychotherapy, University of Munich. Development during the years 1995-2002].

Authors:  T C Baghai; A Marcuse; H-J Möller; R Rupprecht
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.